We invest in

Biotech & Life Sciences early stage ventures in the UK

CMS Ventures is an early-stage investor based in Cambridge investing in Biotech & Life Sciences startups in the UK. We focus on the 4Ds: Drugs, Devices, Diagnostics and Digital.

CMS Ventures, launched in 2020, is the investment arm of China Medical System Holdings Limited (CMS), a well-established, innovation-driven specialty pharma founded in 1995, and listed on the Main Board of the Stock Exchange of Hong Kong Limited (stock code: 867). CMS Ventures receives support from AstraZeneca and Cambridge Judge Business School.

CMS kangzhe
University of Cambridge Judge Business School

Latest News

21 Sep 2020

CMS Ventures invests £500K in game changing Cambridge-based AI startup Qureight

Read more
20 Apr 2020

The unspoken founder’s quest for freedom

Read more
News 4
20 Apr 2020

Cambridge Judge collaborators help in COVID-19 pandemic

Read more

Our People

Meet the individuals behind CMS Ventures and find out more about how their experience and networks can benefit your business

Our Criteria

CMS Ventures provides patient capital for ambitious Biotech and Life Sciences start-ups in the 4Ds (Drugs, Devices, Diagnostics and Digital), interested in entering the Chinese market with a trusted partner of choice.

Find out more

CMS Ventures